People seeking disability support can be affected by how an agency recognizes evidence as well as by the criteria it applies. In its HIV listings rule published December 2, 2016, the Social Security Administration retained guidance for non-definitive documentation. This December 4 weekend account examines that choice, not a Sunday announcement or a finding about anyone's entitlement. [2016-28843][2014-04124]

The February 2014 proposal had sought definitive laboratory documentation and removal of older general CD4 guidance. The final response instead preserves language allowing other acceptable evidence consistent with medical knowledge and the case record. The change matters because a missing definitive test report should not be confused with a rule categorically refusing every other form of documentation. [2016-28843][2014-04124]

That evidentiary flexibility does not abolish the listings' substantive requirements. The final rule revises adult and child HIV criteria and guidance on functional limitations from immune disorders under Social Security's disability programs. Its adult pathways are not all identical: the absolute CD4-count route and the combined-measurement route have different requirements. A broad statement that one laboratory figure always decides the outcome would obscure those distinctions. [2016-28843][2014-04124]

The rule specifies January 17, 2017 effectiveness, later than this retrospective coverage date. Proposal and final text belong to the same SSA proceeding, not independent clinical evidence. For a public-interest reading, the central issue is how specific standards coexist with acceptable alternative documentation. These documents establish that design choice, but do not count additional beneficiaries, demonstrate easier access or provide an individual diagnosis, treatment recommendation or benefits determination. [2016-28843][2014-04124]

Source documents

  1. Revised Medical Criteria for Evaluating Human Immunodeficiency Virus (HIV) Infection and for Evaluating Functional Limitations in Immune System Disordershttps://www.govinfo.gov/content/pkg/FR-2016-12-02/html/2016-28843.htm
  2. Revised Medical Criteria for Evaluating Human Immunodeficiency Virus (HIV) Infection and for Evaluating Functional Limitations in Immune System Disordershttps://www.govinfo.gov/content/pkg/FR-2014-02-26/html/2014-04124.htm